Predicted protein targets (top 16)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.43 |
| ▸ | ALDH1A1 | P00352 | 6/20 | 0.37 |
| ▸ | MAPT | P10636 | 5/20 | 0.37 |
| ▸ | TSHR | P16473 | 2/20 | 0.37 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.37 |
| ▸ | RECQL | P46063 | 1/20 | 0.37 |
| ▸ | MITF | O75030 | 1/20 | 0.35 |
| ▸ | FBP1 | P09467 | 1/20 | 0.34 |
| ▸ | NPC1 | O15118 | 1/20 | 0.34 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.32 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.32 |
| ▸ | HTT | P42858 | 1/20 | 0.32 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.32 |
| ▸ | G6PD | P11413 | 2/20 | 0.32 |
| ▸ | POLB | P06746 | 1/20 | 0.32 |
| ▸ | GAA | P10253 | 1/20 | 0.32 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL9631776 | 0.89 | FBP1 (0.48) | L3MBTL1MAPTRECQLFBP1NPC1 | |
| SCHEMBL22575907 | 0.86 | G6PD (0.47) | L3MBTL1ALDH1A1MAPTTSHRALOX15 | |
| SCHEMBL10448311 | 0.86 | G6PD (0.47) | L3MBTL1ALDH1A1MAPTTSHRALOX15 | |
| SCHEMBL13620526 | 0.83 | FBP1 (0.53) | ALDH1A1MAPTTSHRFBP1NPC1 | |
| SCHEMBL11752668 | 0.83 | APP (0.55) | ALDH1A1MAPTRECQLFBP1NPC1 | |
| SCHEMBL7364017 | 0.82 | FBP1 (0.52) | ALDH1A1MAPTTSHRFBP1TDP1 | |
| SCHEMBL9632547 | 0.78 | ALDH1A1 (0.57) | L3MBTL1ALDH1A1MAPTTSHRRECQL | |
| SCHEMBL9632569 | 0.78 | ALDH1A1 (0.42) | L3MBTL1ALDH1A1MAPTTSHRRECQL | |
| SCHEMBL5615679 | 0.77 | ALDH1A1 (0.33) | ALDH1A1MAPTFBP1HTTNPSR1 | |
| SCHEMBL13100474 | 0.74 | NR1I2 (0.46) | ALDH1A1MAPTRECQLNPC1NPSR1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-8883931-B2 | Polynitrones and use thereof for cross-linking unsaturated polymers | HEINRICH-HEINE-UNIVERSITAT (DE) | 2014-11-11 | — | — | US | disclosed |
| US-20100273910-A1 | POLYNITRONES AND USE THEREOF FOR CROSS-LINKING UNSATURATED POLYMERS | HEINRICH-HEINE-UNIVERSITÄT (DE) | 2010-10-28 | — | — | US | disclosed |
| WO-2009074310-A1 | POLYNITRONS, AND USE THEREOF FOR CROSS-LINKING UNSATURATED POLYMERS | HEINRICH-HEINE-UNIVERSITÄT (DE) | 2009-06-18 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20100273910-A1 | POLYNITRONES AND USE THEREOF FOR CROSS-LINKING UNSATURATED POLYMERS | PNN, MNAT1, NCL | L3MBTL1 2891/4885ALDH1A1 859/4885MAPT 220/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.